Metal-Organic Framework Nanoplatform Synergizes Fenton-Driven Ferroptosis and Photodynamic Apoptosis for Enhanced Hepatocellular Carcinoma Therapy
International Journal of Nanomedicine · 2026-05 · Volume 21 · 1-22
DOI: 10.2147/ijn.s567165 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-05. Verfasst von Shasha Kong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Photochemotherapy, Ferroptosis. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is notorious for its dismal prognosis and resistance to conventional therapies. The integration of multiple cell death mechanisms emerges as a promising strategy to combat the heterogeneity of this malignancy.
Purpose
Herein, we engineered a multifunctional nanoplatform, TPMIL101-TCPP@Lip-HA, by encapsulating the photosensitizer TCPP and chemotherapeutic agent triptolide (TP) within a metal-organic framework (MIL101), followed by surface modification with liposomes and hyaluronic acid. This sophisticated drug delivery system capitalizes on the enhanced permeability and retention effect to achieve tumor-specific accumulation.
Methods
Upon reaching the tumor site, TPMIL101-TCPP@Lip-HA undergoes gradual disintegration, releasing its therapeutic payload. The tumor microenvironment facilitates the reduction of Fe³⁺ to Fe²⁺, triggering ferroptosis through the Fenton reaction. Simultaneously, laser irradiation activates TCPP to generate cytotoxic reactive oxygen species, initiating photodynamic therapy-induced apoptosis. The concomitant accumulation of lipid peroxides synergistically amplifies the ferroptotic cascade.
Results
In vitro/in vivo studies confirm potent anti-HCC efficacy with reduced TP toxicity. Mechanistic studies elucidate that TPMIL101-TCPP@Lip-HA orchestrates ferroptosis through modulation of iron storage and lipid oxidation proteins, while concurrently inducing apoptosis via the cytochrome c/Apaf-1/caspase signaling axis.
Conclusion
These findings collectively underscore TPMIL101-TCPP@Lip-HA as a potent therapeutic nanoplatform capable of arresting HCC progression. The illustration depicts the synthesis and application of nanoparticles for tumor treatment. At the top, chemical structures are shown leading to the formation of MIL101, a nanoparticle. The process involves loading and coupling with TCPP, resulting in TPMIL101. This is further coupled with Lip-HA to form TPMIL101-TCPP at Lip-HA. The nanoparticles are injected into a mouse, targeting tumor cells. The diagram shows tumor cells and normal cells, highlighting the selective targeting of tumor cells. Inside the tumor cell, processes such as reactive oxygen species generation, photodynamic therapy and apoptosis are illustrated. Key components include Fe superscript 3 plus, TP, Lip and HA. The diagram emphasizes the role of these nanoparticles in inducing ferroptosis and apoptosis within tumor cells, while sparing normal cells.Illustration of a nanoparticle synthesis process and its application in tumor treatment in mice. Keywords: hepatocellular carcinoma, Fenton reaction, photodynamic therapy, ferroptosis, apoptosis
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
- Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang, Jiangxi, People's Republic of China.
- Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
- National Medical Products Administration Key Laboratory for Research Evaluation of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Zitieren
APA
Kong, S., Lin, H., Liu, Y., Tang, R., Li, H., & Lin, L. (2026). Metal-Organic Framework Nanoplatform Synergizes Fenton-Driven Ferroptosis and Photodynamic Apoptosis for Enhanced Hepatocellular Carcinoma Therapy. International Journal of Nanomedicine, Volume 21, 1-22. https://doi.org/10.2147/ijn.s567165
Vancouver
Kong S, Lin H, Liu Y, Tang R, Li H, Lin L. Metal-Organic Framework Nanoplatform Synergizes Fenton-Driven Ferroptosis and Photodynamic Apoptosis for Enhanced Hepatocellular Carcinoma Therapy. International Journal of Nanomedicine. 2026;Volume 21:1-22. doi:10.2147/ijn.s567165
BibTeX
@article{Kong2026,
author = {Kong, Shasha and Lin, Hongmei and Liu, Yuling and Tang, Ruying and Li, Hui and Lin, Longfei},
title = {Metal-Organic Framework Nanoplatform Synergizes Fenton-Driven Ferroptosis and Photodynamic Apoptosis for Enhanced Hepatocellular Carcinoma Therapy},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--22},
doi = {10.2147/ijn.s567165}
}
EUVIMED